0001183740-18-000126.txt : 20180709 0001183740-18-000126.hdr.sgml : 20180709 20180709145412 ACCESSION NUMBER: 0001183740-18-000126 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06c FILED AS OF DATE: 20180709 DATE AS OF CHANGE: 20180709 EFFECTIVENESS DATE: 20180709 FILER: COMPANY DATA: COMPANY CONFORMED NAME: PharmaCielo Ltd. CENTRAL INDEX KEY: 0001641777 IRS NUMBER: 000000000 STATE OF INCORPORATION: Z4 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-316289 FILM NUMBER: 18944408 BUSINESS ADDRESS: STREET 1: 82 RICHMOND STREET EAST, SUITE 200 CITY: TORONTO STATE: A6 ZIP: M5C 1P1 BUSINESS PHONE: 6475604640 MAIL ADDRESS: STREET 1: 82 RICHMOND STREET EAST, SUITE 200 CITY: TORONTO STATE: A6 ZIP: M5C 1P1 D 1 primary_doc.xml X0708 D LIVE 0001641777 PharmaCielo Ltd. 82 RICHMOND STREET EAST, SUITE 200 TORONTO A6 ONTARIO, CANADA M5C 1P1 6475604640 CANADA (FEDERAL LEVEL) None None Corporation true 2014 Scott Laitinen 82 Richmond Street East, Suite 200 Toronto A6 ONTARIO, CANADA M5C 1P1 Executive Officer Director Anthony Wile 82 Richmond Street East, Suite 200 Toronto A6 ONTARIO, CANADA M5C 1P1 Executive Officer Director Henning von Koss 82 Richmond Street East, Suite 200 Toronto A6 ONTARIO, CANADA M5C 1P1 Director Carlos Uribe 82 Richmond Street East, Suite 200 Toronto A6 ONTARIO, CANADA M5C 1P1 Director Delon Human 82 Richmond Street East, Suite 200 Toronto A6 ONTARIO, CANADA M5C 1P1 Director David Attard 82 Richmond Street East, Suite 200 Toronto A6 ONTARIO, CANADA M5C 1P1 Director Federico Cock-Correa 82 Richmond Street East, Suite 200 Toronto A6 ONTARIO, CANADA M5C 1P1 Director David Gordon 82 Richmond Street East, Suite 200 Toronto A6 ONTARIO, CANADA M5C 1P1 Director Matteo Pellegrini 82 Richmond Street East, Suite 200 Toronto A6 ONTARIO, CANADA M5C 1P1 Director Simon Langelier 82 Richmond Street East, Suite 200 Toronto A6 ONTARIO, CANADA M5C 1P1 Director Pharmaceuticals Decline to Disclose 06c false 2018-06-25 false true true true true 2,318,944 Subscription Receipts at C$3.35 per Subscription Receipt, convertible into shares upon satisfaction of escrow release conditions at or before September 30, 2018. true In connection with the acquisition of all the issued and outstanding shares of the Issuer by AAJ Capital 1 Corp. ("AAJ") by way of a three-cornered merger pursuant to a merger agreement between the Issuer, AAJ and a wholly-owned subsidiary of AAJ. 17627 5839553 5839553 0 2,318,944 Subscription Receipts were sold at C$3.35 per Subscription Receipt (US$2.52 per Subscription Receipt, based on exchange rate of US$1 : C$1.3303 on June 25, 2018). false 101 0 0 0 false PharmaCielo Ltd. /s/ Scott Laitinen Scott Laitinen Chief Financial Officer 2018-07-07